CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of AKCEA-TTR-LRx in Participants With Transthyretin ‑Mediated Amyloid Cardiomyopathy (ATTR CM)
Condition: Transthyretin‑Mediated Amyloid Cardiomyopathy (ATTR CM) Interventions: Drug: AKCEA-TTR-LRx; Drug: Placebo Sponsors: Ionis Pharmaceuticals, Inc.; Akcea Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials